Literature DB >> 9670292

Boron neutron capture therapy: principles and potential.

R Gahbauer1, N Gupta, T Blue, J Goodman, R Barth, J Grecula, A H Soloway, W Sauerwein, A Wambersie.   

Abstract

This book on the therapeutic applications of neutrons and high-LET radiations in cancer therapy would not have been complete without a review of the present situation of boron neutron capture therapy (BNCT) and a discussion of its future perspectives. BNCT is a special type of high-LET radiation therapy that attempts to achieve a selectivity at the cellular level. The rationale is to incorporate boron atoms selectively in the cancer cells and then bombard those atoms with thermal neutrons to produce a neutron capture reaction and subsequent decay that emits alpha and lithium particles. The efficiency of the technique depends upon achieving selective incorporation of the boron atoms in the cancer cells and not (or to a lesser extent) in the normal cells. The present status and future directions are described, with emphasis on boron carriers (drugs) and their delivery, as well as physical and treatment planning aspects.

Entities:  

Mesh:

Year:  1998        PMID: 9670292     DOI: 10.1007/978-3-642-78774-4_12

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  2 in total

Review 1.  Common challenges and problems in clinical trials of boron neutron capture therapy of brain tumors.

Authors:  N Gupta; R A Gahbauer; T E Blue; B Albertson
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

2.  Accumulation of boron in human malignant glioma cells in vitro is cell type dependent.

Authors:  Maria Dahlström; Jacek Capala; Peter Lindström; Ake Wasteson; Annelie Lindström
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.